Loading company…
Riskpilot
← Back to search
Sign in
Get full access
KARO PHARMA INVEST AS
AS
Active
Org 924548711
Riseveien 9, 4848 Arendal
Economic activity was not specified by tax authority · NACE 0000
Est. 2020
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 0
EBITDA margin
—
+45% vs 2024
Equity ratio
99.9%
Financial strength
Net profit 2025
NOK 237K
+3% vs 2024
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 0
—
EBITDA
NOK -8K
+45%
Net profit
NOK 237K
+3%
Total assets
NOK 741K
+27%
Equity
NOK 740K
+47%
Employees
0
—
Company information
Legal name
KARO PHARMA INVEST AS
Org number
924548711
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
5. februar 2020
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Eie aksjer samt investering og forvaltning av aksjer.
Contact
Address
Riseveien 9, 4848 Arendal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Economic activity was not specified by tax authority
Companies in Arendal
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
245
0
0
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−4
239
−9
−15
−8
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−4
239
−9
−15
−8
Net financials
−0
0
294
245
245
Profit before tax
−4
239
285
230
237
Tax
−0
−0
−0
−0
−0
Net profit
−4
239
285
230
237
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
92
258
504
585
741
Equity
18
257
353
503
740
Long-term debt
74
1
1
1
0
Short-term debt
0
0
150
81
0
Total debt
74
1
151
82
1
Financial ratios
5-year trend
EBITDA margin
-822100.0%
This company
15.8%
Market median
-5203265% vs market
2021
2025
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
2021
2025
Return on equity
32.0%
This company
18.4%
Market median
+74% vs market
2021
2025
Net profit margin
23673600.0%
This company
8.1%
Market median
+292266567% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
RK
Rabih Karouni
Chairman
2020
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
KARO PHARMA INVEST AS
(this company)
NEDENES APOTEK AS
Board network connections
Board members of KARO PHARMA INVEST AS also hold positions in
0
other companies.
Person
Role here
Other companies
Rabih Karouni
Chairman
0 companies